(Q40022106)

16 September 2017

Chylomicron clearance in normal and hyperlipidemic man (English)

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(76)80006-6

25 May 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(76)80006-6

25 May 2022

author name string

S. M. Grundy

series ordinal

1

1 reference

PubMed ID

185486

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185486

25 May 2022

H. Y. Mok

series ordinal

2

1 reference

PubMed ID

185486

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185486

25 May 2022

language of work or name

1 reference

1 November 1976

1 reference

full work available at URL

16 September 2017

15

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0026049576800066?httpAccept=text/xml

0 references

https://api.elsevier.com/content/article/PII:S0026049576800066?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(76)80006-6

25 May 2022

1 reference

16 September 2017

25

1 reference

16 September 2017

11

1 reference

16 September 2017

1225-1239

1 reference

Sites of lipoprotein lipase activity in adipose tissue perfused with chylomicrons. Electron microscope cytochemical study

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

The metabolism of chylomicron cholesterol ester in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Particulate Fat in Lymph and Blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

A Methodological Study of an Intravenous Fat Tolerance Test with IntralipidREmulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Disposal of Human Chylomicrons Administered Intravenously in Ischemic Heart Disease and Essential Hyperlipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Reappraisal of the role of insulin in hypertriglyceridemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Kinetics of triglyceride turnover of very low density lipoproteins of human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Measurement of Plasma Triglyceride Turnover in the Study of Hyperglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Clofibrate and nafenopin (SU-13437): effects on plasma clearance and tissue distribution of chylomicron triglyceride in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Mechanism of the hypolipemic effect of clofibrate in postabsorptive man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

Heterogeneity in the rate of plasma clearance of chylomicrons of different size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980006-6

inferred from DOI database lookup

7 January 2021

based on heuristic

familial hyperlipidemia

9

545

Fredrickson

1972

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(76)80006-6

25 May 2022

Identifiers

1 reference

16 September 2017

1 reference

PubMed ID

185486